NovaBay closes $12M acquisition of DERMAdoctor; founders appointed to leadership, board seat planned

Stablecoin Development Corp

Acquisition of DERMAdoctor closed Nov 5, 2021 for $12M cash plus up to $3M earn-out over 2 years.
Co-founders Dr. Audrey Kunin (Chief Product Officer) and Dr. Jeff Kunin (President) appointed; base salaries $200K and $150K respectively.
Dr. Audrey Kunin to be appointed to NovaBay Board as Class I director no later than 2022 annual meeting.
Funded by working capital and private placement of Series B preferred & warrants raising $15M gross proceeds.
Q3 2021 earnings call scheduled for Nov 11 at 4:30 PM ET; will discuss combined company plans.

item 2.01 item 5.02 item 7.01 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Audrey Kunin

Chief Product Officer

SDEV · Stablecoin Development Corp

Effective: 2021-11-05
Filed: November 12, 2021, 6:59 PM ET

Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor’s Chief Product Officer and President, respectively.

Appointed

Dr. Jeff Kunin

President

SDEV · Stablecoin Development Corp

Effective: 2021-11-05
Filed: November 12, 2021, 6:59 PM ET

Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor’s Chief Product Officer and President, respectively.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Audrey Kunin was appointed as Chief Product Officer at Stablecoin Development Corp.

Action: appointed
Role: Chief Product Officer

Exact text from the filing

Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor’s Chief Product Officer and President, respectively.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Jeff Kunin was appointed as President at Stablecoin Development Corp.

Action: appointed
Role: President

Exact text from the filing

Drs. Audrey Kunin and Jeff Kunin were appointed to serve as DERMAdoctor’s Chief Product Officer and President, respectively.

View on SEC.gov

Stablecoin Development Corp filing history →

Source: SEC EDGAR

accession 0001437749-21-026234

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.